Skip to main content

Table 1 Classification of outcomes of SmartEye compared with clinicians

From: The diagnostic accuracy of an intelligent and automated fundus disease image assessment system with lesion quantitative function (SmartEye) in diabetic patients

Clinicians diagnosis SmartEye diagnosis
DR0 DR1 DR2 DR3 PRP Other diseases Disqualification Total
  N(%) N(%) N(%) N(%) N(%) N(%) N(%) N(%)
No DR 5377 (58.0%) 290 (3.1%) 782 (8.4%) 223 (2.4%) 23 (0.2%) 74 (0.8%) 2497 (26.9%) 9266 (100.0%)
Mild NPDR 213 (34.5%) 152 (24.6%) 88 (14.2%) 5 (0.8%) 1 (0.2%) 7 (1.1%) 152 (24.6%) 618 (100.0%)
Moderate NPDR 176 (14.8%) 111 (9.3%) 583 (49.0%) 129 (10.8%) 3 (0.3%) 4 (0.3%) 184 (15.5%) 1190 (100.0%)
Severe NPDR 0 (0.0%) 0 (0.0%) 6 (8.3%) 65 (90.3%) 0 (0.0%) 0 (0.0%) 1 (1.4%) 72 (100.0%)
PDR 0 (0.0%) 0 (0.0%) 1 (8.3%) 8 (66.7%) 0 (0.0%) 0 (0.0%) 3 (25.0%) 12 (100.0%)
PRP 5 (4.9%) 5 (4.9%) 28 (27.5%) 20 (19.6%) 28 (27.5%) 0 (0.0%) 16 (15.7%) 102 (100.0%)
Other diseases 39 (14.2%) 10 (3.6%) 71 (25.8%) 86 (31.3%) 17 (6.2%) 1 (0.4%) 51 (18.5%) 275 (100.0%)
Disqualification 203 (2.4%) 50 (0.6%) 595 (7.1%) 391 (4.7%) 30 (0.4%) 3 (0.0%) 7097 (84.8%) 8369 (100.0%)
Total 6013 (30.2%) 618 (3.1%) 2154 (10.8%) 927 (4.7%) 102 (0.5%) 10,001 (50.2%) 89 (0.4%) 19,904 (100.0%)